Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
Patients with asthma and Chronic Obstructive Respiratory Disease (COPD) rely on three main device classes for inhalation therapy: metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and soft-mist inhalers (SMIs). The carbon footprint (CF) of these inhalers differs with MDIs having a higher impa...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/7/1/e000571.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850129518104150016 |
|---|---|
| author | Sara Panigone Federica Sandri Rossella Ferri Andrea Volpato Elena Nudo Gabriele Nicolini |
| author_facet | Sara Panigone Federica Sandri Rossella Ferri Andrea Volpato Elena Nudo Gabriele Nicolini |
| author_sort | Sara Panigone |
| collection | DOAJ |
| description | Patients with asthma and Chronic Obstructive Respiratory Disease (COPD) rely on three main device classes for inhalation therapy: metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and soft-mist inhalers (SMIs). The carbon footprint (CF) of these inhalers differs with MDIs having a higher impact than DPIs and SMIs due to the propellant in MDIs. However, the certified CF of specific MDI products may differ significantly. MDIs still represent an essential option for many patients. Consequently, novel approaches shall be considered to balance environmental goals with patient health and well-being while maintaining a diverse range of choices for patients and physicians. |
| format | Article |
| id | doaj-art-a59ca509277841a39c835df9f29bac76 |
| institution | OA Journals |
| issn | 2052-4439 |
| language | English |
| publishDate | 2020-09-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open Respiratory Research |
| spelling | doaj-art-a59ca509277841a39c835df9f29bac762025-08-20T02:32:56ZengBMJ Publishing GroupBMJ Open Respiratory Research2052-44392020-09-017110.1136/bmjresp-2020-000571Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatmentSara Panigone0Federica Sandri1Rossella Ferri2Andrea Volpato3Elena Nudo4Gabriele Nicolini5Corporate Marketing, Chiesi Farmaceutici SpA, Parma, ItalyCorporate Marketing, Chiesi Farmaceutici SpA, Parma, ItalyCorporate Health Safety & Environment, Chiesi Farmaceutici SpA, Parma, ItalyCorporate Health Safety & Environment, Chiesi Farmaceutici SpA, Parma, ItalyGlobal Medical Affairs, Chiesi Farmaceutici SpA, Parma, ItalyGlobal Medical Affairs, Chiesi Farmaceutici SpA, Parma, ItalyPatients with asthma and Chronic Obstructive Respiratory Disease (COPD) rely on three main device classes for inhalation therapy: metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and soft-mist inhalers (SMIs). The carbon footprint (CF) of these inhalers differs with MDIs having a higher impact than DPIs and SMIs due to the propellant in MDIs. However, the certified CF of specific MDI products may differ significantly. MDIs still represent an essential option for many patients. Consequently, novel approaches shall be considered to balance environmental goals with patient health and well-being while maintaining a diverse range of choices for patients and physicians.https://bmjopenrespres.bmj.com/content/7/1/e000571.full |
| spellingShingle | Sara Panigone Federica Sandri Rossella Ferri Andrea Volpato Elena Nudo Gabriele Nicolini Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment BMJ Open Respiratory Research |
| title | Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment |
| title_full | Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment |
| title_fullStr | Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment |
| title_full_unstemmed | Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment |
| title_short | Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment |
| title_sort | environmental impact of inhalers for respiratory diseases decreasing the carbon footprint while preserving patient tailored treatment |
| url | https://bmjopenrespres.bmj.com/content/7/1/e000571.full |
| work_keys_str_mv | AT sarapanigone environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment AT federicasandri environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment AT rossellaferri environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment AT andreavolpato environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment AT elenanudo environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment AT gabrielenicolini environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment |